| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/22/2009 | CN100515420C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/21/2009 | US7563881 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 07/21/2009 | US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases |
| 07/21/2009 | US7563822 active ingredient a 5-amidino-2-hydroxybenzenesulfonamide derivative or a pharmaceutical acceptable salt thereof; excellent inhibitory effect on mesangial cell proliferation and decreasing effect on urine protein excretion |
| 07/21/2009 | US7563809 Nociceptin analogs |
| 07/21/2009 | US7563797 Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands |
| 07/21/2009 | US7563793 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563778 Antisense oligonucleotide preparation method |
| 07/21/2009 | US7563593 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 07/21/2009 | US7563459 Administering a glycoconjugated asialoorosomucoid and the stem cell to the mammal for drug delivering to a target tissue; regenerating heart tissue; tissue-targeted therapy, gene therapy |
| 07/21/2009 | US7563450 UL16 binding protein 4 |
| 07/21/2009 | CA2514750C Methods and compositions utilizing astaxanthin |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2382098C Sustained-release, oral pharmaceutical forms of administration |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/21/2009 | CA2328528C Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/16/2009 | WO2009089149A1 B7-h1 (cd274) antagonists induce apoptosis of tumor cells |
| 07/16/2009 | WO2009087987A1 Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly |
| 07/16/2009 | WO2009087285A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/16/2009 | WO2009087175A2 Allergy vaccine composition for mucosal administration |
| 07/16/2009 | WO2009086656A1 Y-type polyethylene glycol modified g-csf and preparation method and use thereof |
| 07/16/2009 | WO2009086640A1 Adjuvant compositions comprising poly-ic and a cationic polymer |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 07/16/2009 | WO2009046860A3 Use of dago as a therapeutic agent |
| 07/16/2009 | WO2009046859A3 Use of af12198 and dago as therapeutic agents |
| 07/16/2009 | WO2009040035A3 Use of a peptide as a therapeutic agent |
| 07/16/2009 | WO2009039990A3 Use of icam peptide as a therapeutic agent |
| 07/16/2009 | WO2009039974A3 Use of peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/16/2009 | WO2009038913A3 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis |
| 07/16/2009 | WO2009033817A3 Use of the combination of the hcv-1 e2 protein (484-499) and the human pancreatic polypeptide as a therapeutic agent |
| 07/16/2009 | WO2009033766A3 Use of a peptide as a therapeutic agent |
| 07/16/2009 | WO2008125903A3 Method of inhibiting an undesired immune response |
| 07/16/2009 | WO2008125366A3 Treatment of autoimmune diseases |
| 07/16/2009 | WO2008100576A3 Sustained delivery formulations of rapamycin compounds |
| 07/16/2009 | WO2008094942A8 Humanized antibodies against cxcr3 |
| 07/16/2009 | WO2008040111A8 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/16/2009 | US20090182058 Novel Chalcone Derivatives With Antimitotic Activity |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090182034 containing preponderance of cis doxepin isomer over trans doxepin isomer; decreased sedative effects; conjunctivitis |
| 07/16/2009 | US20090182012 Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders |
| 07/16/2009 | US20090181987 Inhibitors of brutons tyrosine kinase |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 07/16/2009 | US20090181959 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 07/16/2009 | US20090181950 Histamine Receptor Antagonists Comprising an Azepin Core |
| 07/16/2009 | US20090181948 Diamine derivative |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090181046 Capsid Proteins and Uses Therefore |
| 07/16/2009 | US20090181045 Tat-based vaccine compositions and methods of making and using same |
| 07/16/2009 | US20090181043 Method for Producing Human Anti-Thymocyte Immunoglobulins |
| 07/16/2009 | US20090181029 Methods for treating interleukin-6 related diseases |
| 07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
| 07/16/2009 | US20090181015 Humanized anti-cd40 antibodies and their methods of use |
| 07/16/2009 | US20090181012 Method for detecting regulatory t cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the compostion |
| 07/16/2009 | US20090181011 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
| 07/16/2009 | US20090180996 Epigenetic modification of cell phenotype, fate and/or function by RNA transfer |
| 07/16/2009 | DE10301300B4 Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein Use of acylated 4-amidino and 4-Guanidinobenzylaminen for the inhibition of plasma kallikrein |
| 07/16/2009 | CA2711862A1 Composition for improving nutritional status of the elderly, reducing frequency of fever of the elderley and/or increasing immunocompetence of the elderly |
| 07/16/2009 | CA2710841A1 Y-shaped polyethylene glycol modified g-csf, the preparation and use thereof |
| 07/16/2009 | CA2708406A1 Allergy vaccine composition for mucosal administration |
| 07/16/2009 | CA2702012A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078525A2 Treatment of tuberculosis using immunomodulator compounds |
| 07/15/2009 | EP2078522A1 Composition for treating allergy |
| 07/15/2009 | EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 07/15/2009 | EP2078082A1 Recombinant human interferon-like proteins |
| 07/15/2009 | EP2078080A2 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
| 07/15/2009 | EP2078027A1 Cathepsin proteases inhibitors |
| 07/15/2009 | EP2078026A1 Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| 07/15/2009 | EP2077839A2 Soluble epoxide hydrolase inhibitors for the treatment of rheumatoid arthritis |
| 07/15/2009 | EP2077821A1 Compositions and methods for modulating immune responses |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | EP1061949B1 Cytokines and mitogens to inhibit graft-versus-host disease |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513565C Apoptin-associating protein |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100512842C Disinfectant |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/14/2009 | US7560591 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560561 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate |
| 07/14/2009 | US7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560487 In particular, kidneys |
| 07/14/2009 | US7560484 Active ingredients of 9,12,13-trihydroxy-10-octadecenoic acid and derivatives as safe and effective vaccine adjuvants; side effects reduction; immunopotentiation; plant extracts; viral diseases; inoculation intranasal, transdermal, oral |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |